Vaxcyte Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $47.0M | $392.8M | $386.2M |
| FY2021 | $40.3M | $324.3M | $69.0M |
| FY2022 | $52.6M | $1.01B | $834.7M |
| FY2023 | $167.4M | $1.41B | $397.5M |
| FY2024 | $205.5M | $3.51B | $387.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $47.0M | $392.8M | $386.2M |
| FY2021 | $40.3M | $324.3M | $69.0M |
| FY2022 | $52.6M | $1.01B | $834.7M |
| FY2023 | $167.4M | $1.41B | $397.5M |
| FY2024 | $205.5M | $3.51B | $387.9M |